The
global Apheresis
Equipment Market size is expected to reach USD 3.7 billion by 2024,
according to a new report by Grand View Research, Inc. The apheresis equipment
industry is expected to be impacted by factors such as rising demand for
plasma, platelets and other blood components, increasing incidence of chronic
illnesses, presence and development of ideal reimbursement policies across
various regions, and supportive government initiatives.
The
U.S. Federal Government has been very involved in the funding of apheresis
research through its benefit programs such as Medicare, Medicaid, veterans’
health administration military and employee insurance programs. Medicare
provides coverage for apheresis regardless of whether the procedure is
performed in a hospital or a blood center. In addition, private insurers have
recently begun to closely examine apheresis procedures and issue policy
statements pertaining to coverage.
Growing
incidence of blood related disorders leading to the rise in demand for
platelets and plasma is expected to serve the market as a high impact rendering
driver. The industry is also expected to be driven by technology innovations
aimed at delivering relatively more effective and faster results. Healthcare
practitioners and researchers are now in the need for devices requiring minimum
human intervention and introduction of fully automatic apheresis equipment with
enhanced displays is expected to improve usage rates.
Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/apheresis-equipment-market
Further Key Findings From the Study Suggest:
- Disposable
apheresis kits are anticipated to dominate the product segment by 2024.
Bulk volume purchase associated with these products is predicted to govern
their growth.A single cycle of apheresis procedure consumes multiple
disposable sub parts which is responsible for comparatively larger market
volume as compared to apheresis machines.
- The
photopheresis procedure is anticipated to witness lucrative growth owing
to its rising demand in treatment. The procedure is approved for treatment
of solid organ transplant rejection, scleroderma, type 1 diabetes,
pemphigus vulgaris, lichen planus &atopic dermatitis, and cutaneous
T-cell lymphoma.
- Another
procedure expected to gain lucrative share is erythrocytapheresis. The
procedure also finds application in blood donation procedures where it is
widely used for separating two units of blood, known as double red cell
apheresis. Rising incidence rates of genetic disorders such as sickle cell
anemia is expected to drive apheresis equipment market growth by widening
the patient base.
- Asia Pacific
is anticipated to witness the fastest growth over the forecast period.
Presence of high unmet needs and rapidly increasing demand for platelets
in the emerging Asia Pacific and Latin American markets is expected to
serve this market as future growth opportunities. For example, in July,
2014, India witnessed a rapid rise in demand for platelets owing to an
increased incidence rate of dengue.
- Key players
of this industry include Fresenius Kabi; Haemonetics; Terumo BCT;
Therakos, Inc.; Asahi Kasei Kuraray Medical Co Ltd; and B. Braun Melsungen
AG. Strategies promoting faster distribution and development of efficient
supply chain are being incorporated by the players.
- For
instance, in March 2014, Therakos, Inc., signed an exclusive distribution
agreement with Terumo BCT, wherein Terumo would be the sole supplier of
UVAR XTS and THERAKOS CELLEX in the Latin American region. Countries such
as Mexico, Argentina, Peru, Colombia and Uruguay would be under purview.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment